Scholars Central

Conference abstract

TE-MPN- Thrombotic events in myeloproliferative neoplasms: JAK2V617F mutation as a predictive marker

Authors: Adel Gouri

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Thrombotic complications are a common cause of morbidity and mortality in patients with myeloproliferative neoplasms (MPNs), particularly polycythemia vera (PV) and essential thrombocythemia (ET). The pathogenesis of thrombosis in MPN is multifactorial and complex. Recently, several studies suggest that JAK2V617F mutation plays an important role in the pathogenesis of thrombosis. This mutation is present in almost all the PV patients and in 50-60% of ET patients. This relationship suggests a direct influence of the JAK2 mutation on the hemostatic system. Current data indicate that JAK2V617F mutation positivity seem to be predictive biomarker of cardiovascular and thrombotic complications in patients with MPN. However, future research should focus on the pathophysiology of thrombosis in myeloproliferative disorders, particularly in terms of the relationship between dysregulated Janus kinase 2 and thrombotic risks.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Blood Disorders & Transfusion.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Blood Disorders & Transfusion
  • SubjectHaematology
  • BylineArticles whose byline prints “Adel Gouri”